Orexo AB v. Actavis Elizabeth LLC

Application Number	Patent Number	External Links
-	US8454996	Espacenet Google Patents

COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2094121.) - filed by Orexo US, Inc., Orexo AB. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(ceg) (Entered: 02/28/2017)

2017-02-28

1

View

COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2094121.) - filed by Orexo US, Inc., Orexo AB. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(ceg) (Entered: 02/28/2017)

2017-02-28

2

View

COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2094121.) - filed by Orexo US, Inc., Orexo AB. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(ceg) (Entered: 02/28/2017)

2017-02-28

2

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) (Entered: 02/28/2017)

2017-02-28

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,454,996 B2. (ceg) (Entered: 02/28/2017)

2017-02-28

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Orexo AB for Orexo US, Inc. filed by Orexo AB, Orexo US, Inc. (ceg) (Entered: 02/28/2017)

2017-02-28

1

View

SUMMONS Returned Executed by Orexo US, Inc., Orexo AB. Actavis Elizabeth LLC served on 3/1/2017, answer due 3/22/2017. (Fahnestock, Derek) (Entered: 03/01/2017)

2017-03-01

1

View

SUMMONS Returned Executed by Orexo US, Inc., Orexo AB. Actavis Pharma, Inc. served on 3/1/2017, answer due 3/22/2017. (Fahnestock, Derek) (Entered: 03/01/2017)

2017-03-01

1

View

SUMMONS Returned Executed by Orexo US, Inc., Orexo AB. Teva Pharmaceuticals USA, Inc. served on 3/1/2017, answer due 3/22/2017. (Fahnestock, Derek) (Entered: 03/01/2017)

2017-03-01

1

View

STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to April 21, 2017 - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Phillips, John) (Entered: 03/16/2017)

2017-03-16

1

View

STIPULATION TO EXTEND TIME for Defendant Teva Pharmaceutical Industries, Ltd. to move, answer or otherwise respond to the Complaint (D.I. 1) to April 21, 2017 - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Phillips, John) (Entered: 03/17/2017)

2017-03-17

1

View

SUMMONS Returned Executed by Orexo US, Inc., Orexo AB. Teva Pharmaceutical Industries, Ltd. served on 3/17/2017, answer due 4/21/2017. (Fahnestock, Derek) (Entered: 03/21/2017)

2017-03-21

1

View

MOTION for Pro Hac Vice Appearance of Attorney Errol B. Taylor, Fredrick M. Zullow, Anna Brook, Jordan P. Markham, and Kyanna Lewis - filed by Orexo AB, Orexo US, Inc.. (Fahnestock, Derek) (Entered: 03/21/2017)

2017-03-21

1

View

STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to April 28, 2017 - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Bilson, David) (Entered: 04/20/2017)

2017-04-20

1

View

MOTION to Strike and Dismiss Complaint Under Fed. R. Civ. P. 12(f) and 12(b)(6) - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Text of Proposed Order)(Phillips, John) Modified on 5/1/2017 (mdb). (Entered: 04/28/2017)

2017-04-28

1

View

MOTION to Strike and Dismiss Complaint Under Fed. R. Civ. P. 12(f) and 12(b)(6) - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Text of Proposed Order)(Phillips, John) Modified on 5/1/2017 (mdb). (Entered: 04/28/2017)

2017-04-28

2

View

[SEALED] OPENING BRIEF in Support re 13 MOTION to Strike and Dismiss Complaint Under Fed. R. Civ. P. 12(f) and 12(b)(6) filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc..Answering Brief/Response due date per Local Rules is 5/12/2017. (Attachments: # 1 Exhibit A - G)(Phillips, John) Modified on 5/1/2017 (mdb). (Entered: 04/28/2017)

2017-04-28

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceuticals Industries Ltd. for Actavis Elizabeth LLC filed by Actavis Elizabeth LLC. (Phillips, John) (Entered: 04/28/2017)

2017-04-28

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Actavis Pharma, Inc. filed by Actavis Pharma, Inc.. (Phillips, John) (Entered: 04/28/2017)

2017-04-28

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Phillips, John) (Entered: 04/28/2017)

2017-04-28

1

View

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Teva Pharmaceutical Industries, Ltd.. (Phillips, John) (Entered: 04/28/2017)

2017-04-28

1

View

REDACTED VERSION of 14 Opening Brief in Support, by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibits)(Phillips, John) (Entered: 05/05/2017)

2017-05-05

1

View

REDACTED VERSION of 14 Opening Brief in Support, by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibits)(Phillips, John) (Entered: 05/05/2017)

2017-05-05

2

View

MOTION for Pro Hac Vice Appearance of Attorney George C. Lombardi, Ivan Poullaos and Tyler Johannes - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Certification of George C. Lombardi, # 2 Certification of Ivan Poullaos, # 3 Certification of Tyler Johannes)(Bilson, David) (Entered: 05/08/2017)

2017-05-08

1

View

MOTION for Pro Hac Vice Appearance of Attorney George C. Lombardi, Ivan Poullaos and Tyler Johannes - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Certification of George C. Lombardi, # 2 Certification of Ivan Poullaos, # 3 Certification of Tyler Johannes)(Bilson, David) (Entered: 05/08/2017)

2017-05-08

2

View

MOTION for Pro Hac Vice Appearance of Attorney George C. Lombardi, Ivan Poullaos and Tyler Johannes - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Certification of George C. Lombardi, # 2 Certification of Ivan Poullaos, # 3 Certification of Tyler Johannes)(Bilson, David) (Entered: 05/08/2017)

2017-05-08

2

View

MOTION for Pro Hac Vice Appearance of Attorney George C. Lombardi, Ivan Poullaos and Tyler Johannes - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Certification of George C. Lombardi, # 2 Certification of Ivan Poullaos, # 3 Certification of Tyler Johannes)(Bilson, David) (Entered: 05/08/2017)

2017-05-08

2

View

MOTION for Pro Hac Vice Appearance of Attorney Michael K. Nutter - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Certification of Michael K. Nutter)(Bilson, David) (Entered: 05/11/2017)

2017-05-11

1

View

MOTION for Pro Hac Vice Appearance of Attorney Michael K. Nutter - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Certification of Michael K. Nutter)(Bilson, David) (Entered: 05/11/2017)

2017-05-11

2

View

[SEALED] ANSWERING BRIEF in Opposition re 13 MOTION to Strike and Dismiss Complaint Under Fed. R. Civ. P. 12(f) and 12(b)(6) filed by Orexo AB, Orexo US, Inc..Reply Brief due date per Local Rules is 5/19/2017. (Attachments: # 1 Exhibit A-I)(Fahnestock, Derek) Modified on 5/15/2017 (mdb). (Entered: 05/12/2017)

2017-05-12

1

View

REDACTED VERSION of 22 Answering Brief in Opposition, by Orexo AB, Orexo US, Inc.. (Attachments: # 1 Exhibit A-I)(Fahnestock, Derek) (Entered: 05/19/2017)

2017-05-19

1

View

REDACTED VERSION of 22 Answering Brief in Opposition, by Orexo AB, Orexo US, Inc.. (Attachments: # 1 Exhibit A-I)(Fahnestock, Derek) (Entered: 05/19/2017)

2017-05-19

2

View

[SEALED] REPLY BRIEF re 13 MOTION to Strike and Dismiss Complaint Under Fed. R. Civ. P. 12(f) and 12(b)(6) filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit H)(Phillips, John) Modified on 5/22/2017 (mdb). (Entered: 05/19/2017)

2017-05-19

1

View

REDACTED VERSION of 24 Reply Brief, by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit H)(Phillips, John) (Entered: 05/26/2017)

2017-05-26

1

View

REDACTED VERSION of 24 Reply Brief, by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit H)(Phillips, John) (Entered: 05/26/2017)

2017-05-26

2

View

MOTION to Stay Discovery - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Text of Proposed Order)(Phillips, John) Modified on 7/11/2017 (mdb). (Entered: 07/11/2017)

2017-07-11

1

View

MOTION to Stay Discovery - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Text of Proposed Order)(Phillips, John) Modified on 7/11/2017 (mdb). (Entered: 07/11/2017)

2017-07-11

2

View

OPENING BRIEF in Support re 26 MOTION to Stay Discovery filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc..Answering Brief/Response due date per Local Rules is 7/25/2017. (Phillips, John) Modified on 7/11/2017 (mdb). (Entered: 07/11/2017)

2017-07-11

1

View

ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 7/11/2017. (asw) (Entered: 07/11/2017)

2017-07-11

1

View

ANSWERING BRIEF in Opposition re 26 MOTION to Stay Discovery filed by Orexo AB, Orexo US, Inc..Reply Brief due date per Local Rules is 8/1/2017. (Attachments: # 1 Exhibits A-E)(Fahnestock, Derek) (Entered: 07/25/2017)

2017-07-25

1

View

ANSWERING BRIEF in Opposition re 26 MOTION to Stay Discovery filed by Orexo AB, Orexo US, Inc..Reply Brief due date per Local Rules is 8/1/2017. (Attachments: # 1 Exhibits A-E)(Fahnestock, Derek) (Entered: 07/25/2017)

2017-07-25

2

View

REPLY BRIEF re 26 MOTION to Stay Discovery filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Phillips, John) (Entered: 08/01/2017)

2017-08-01

1

View

Joint STATUS REPORT by Orexo AB, Orexo US, Inc.. (Fahnestock, Derek) (Entered: 08/10/2017)

2017-08-10

1

View

Joint PROPOSED ORDER - [Proposed] Scheduling Order by Orexo AB, Orexo US, Inc.. (Fahnestock, Derek) (Entered: 08/10/2017)

2017-08-10

1

View

NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Documents and Things to Defendant (Request Nos. 1-62) filed by Orexo AB, Orexo US, Inc..(Fahnestock, Derek) (Entered: 08/16/2017)

2017-08-16

1

View

NOTICE OF SERVICE of Defendants Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical USA, Inc. and Teva Pharmaceutical Industries, Ltd.'s Objections to Plaintiffs' First Set of Requests for Documents and Things to Defendant (Request Nos. 1-62) filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc..(Phillips, John) (Entered: 09/07/2017)

2017-09-07

1

View

Letter to The Honorable Gregory M. Sleet from Derek J. Fahnestock regarding parties jointly submit plaintiffs' request that the Court compel Defendants to move forward with discovery and Defendants' position that discovery should not proceed while the Court considers Defendants' motion to stay pending their motion to dismiss (D.I. 26) - re 26 MOTION to Stay Discovery. (Fahnestock, Derek) (Entered: 09/18/2017)

2017-09-18

1

View

Official Transcript of T/C held on 09 25 17 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 10/16/2017. Redacted Transcript Deadline set for 10/26/2017. Release of Transcript Restriction set for 12/27/2017. (kjm) (Entered: 09/25/2017)

2017-09-25

1

View

Letter to The Honorable Gregory M. Sleet from Derek J. Fahnestock regarding the parties' respective discovery plans - re 13 MOTION to Strike and Dismiss Complaint Under Fed. R. Civ. P. 12(f) and 12(b)(6). (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Fahnestock, Derek) Modified on 10/3/2017 (mdb). (Entered: 10/02/2017)

2017-10-02

1

View

Letter to The Honorable Gregory M. Sleet from Derek J. Fahnestock regarding the parties' respective discovery plans - re 13 MOTION to Strike and Dismiss Complaint Under Fed. R. Civ. P. 12(f) and 12(b)(6). (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Fahnestock, Derek) Modified on 10/3/2017 (mdb). (Entered: 10/02/2017)

2017-10-02

2

View

Letter to The Honorable Gregory M. Sleet from Derek J. Fahnestock regarding the parties' respective discovery plans - re 13 MOTION to Strike and Dismiss Complaint Under Fed. R. Civ. P. 12(f) and 12(b)(6). (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Fahnestock, Derek) Modified on 10/3/2017 (mdb). (Entered: 10/02/2017)

2017-10-02

2

View

ORDER appointing Special Master: Charles H. Toliver, IV appointed. See order for details. Signed by Judge Gregory M. Sleet on 10/10/2017. (mdb) (Entered: 10/10/2017)

2017-10-10

1

View

NOTICE OF SERVICE of Defendants Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd.'s Objections and Responses to Plaintiffs' First Set of Requests for Documents and Things to Defendant (Request Nos. 1-62) filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc..(Phillips, John) (Entered: 10/16/2017)

2017-10-16

1

View

MOTION for Pro Hac Vice Appearance of Attorney Jordan D. Mobley - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Certification of Jordan D. Mobley)(Bilson, David) (Entered: 10/16/2017)

2017-10-16

1

View

MOTION for Pro Hac Vice Appearance of Attorney Jordan D. Mobley - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Certification of Jordan D. Mobley)(Bilson, David) (Entered: 10/16/2017)

2017-10-16

2

View

PROPOSED ORDER - GRANTED - Order Under Rule 502(d) Of The Federal Rules of Evidence re 38 Order Appointing Special Master by Charles H. Toliver, IV. (Toliver, Charles) (Entered: 10/17/2017)

2017-10-17

1

View

PROPOSED ORDER -- Scheduling Order -- by Orexo AB, Orexo US, Inc.. (Attachments: # 1 Letter to the Honorable Gregory M. Sleet)(Fahnestock, Derek) (Entered: 11/03/2017)

2017-11-03

1

View

PROPOSED ORDER -- Scheduling Order -- by Orexo AB, Orexo US, Inc.. (Attachments: # 1 Letter to the Honorable Gregory M. Sleet)(Fahnestock, Derek) (Entered: 11/03/2017)

2017-11-03

2

View

NOTICE OF SERVICE of Defendants Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltds Rule 26(a)(1) Initial Disclosures filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc..(Bilson, David) (Entered: 11/14/2017)

2017-11-14

1

View

NOTICE OF SERVICE of Initial Disclosures of Plaintiffs Orexo AB and Orexo US, Inc. Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Orexo AB, Orexo US, Inc..(Fahnestock, Derek) (Entered: 11/14/2017)

2017-11-14

1

View

NOTICE OF SERVICE of (1) Defendants' First Set of Interrogatories to Plaintiffs; and (2) Defendants' First Set of Requests to Plaintiffs for the Production of Documents filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc..(Bilson, David) (Entered: 12/04/2017)

2017-12-04

1

View

Official Transcript of Conference held on 12 04 17 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 1/2/2018. Redacted Transcript Deadline set for 1/8/2018. Release of Transcript Restriction set for 3/8/2018. (kjm) (Entered: 12/08/2017)

2017-12-08

1

View

PROPOSED ORDER -- Scheduling Order -- by Orexo AB, Orexo US, Inc.. (Attachments: # 1 Letter to the Honorable Gregory M. Sleet)(Fahnestock, Derek) (Entered: 12/08/2017)

2017-12-08

1

View

PROPOSED ORDER -- Scheduling Order -- by Orexo AB, Orexo US, Inc.. (Attachments: # 1 Letter to the Honorable Gregory M. Sleet)(Fahnestock, Derek) (Entered: 12/08/2017)

2017-12-08

2

View

NOTICE OF SERVICE of (1) Plaintiffs' Second Set of Requests for Documents and Things to Defendant (Request Nos. 63-95); (2) Plaintiffs' Delaware Default Standard 4(a) Disclosure filed by Orexo AB, Orexo US, Inc..(Fahnestock, Derek) (Entered: 12/08/2017)

2017-12-08

1

View

NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Defendants (Interrogatory No. 1) filed by Orexo AB, Orexo US, Inc..(Fahnestock, Derek) (Entered: 12/12/2017)

2017-12-12

1

View

ANSWER to 1 Complaint, with Jury Demand, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Actavis Pharma, Inc., Actavis Elizabeth LLC, Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries, Ltd..(Phillips, John) Modified on 12/18/2017 (mdb). (Entered: 12/15/2017)

2017-12-15

1

View

REDACTED VERSION of CORRECTING ENTRY:, 50 Answer to Complaint,, Counterclaim, by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Phillips, John) (Entered: 12/15/2017)

2017-12-15

1

View

Joint STIPULATION TO EXTEND TIME for Plaintiffs to answer, move, or otherwise respond to Defendants' Answer, Affirmative Defenses, and Counterclaims [D.I. 50] to January 19, 2018 - filed by Orexo AB, Orexo US, Inc.. (Fahnestock, Derek) (Entered: 12/27/2017)

2017-12-27

1

View

Letter to The Honorable Gregory M. Sleet from Derek J. Fahnestock regarding Plaintiffs' Opening Letter Brief Regarding Issue Preclusion. (Attachments: # 1 Exhibit A-C)(Fahnestock, Derek) (Entered: 12/29/2017)

2017-12-29

1

View

Letter to The Honorable Gregory M. Sleet from Derek J. Fahnestock regarding Plaintiffs' Opening Letter Brief Regarding Issue Preclusion. (Attachments: # 1 Exhibit A-C)(Fahnestock, Derek) (Entered: 12/29/2017)

2017-12-29

2

View

NOTICE OF SERVICE of (1) Plaintiffs' Responses and Objections to Defendants' First Set of Requests for the Production of Documents and Things (Nos. 1-120); and (2) Plaintiffs' Responses and Objections to Defendants' First Set of Interrogatories (Nos. 1-13) filed by Orexo AB, Orexo US, Inc..(Fahnestock, Derek) (Entered: 01/03/2018)

2018-01-03

1

View

NOTICE OF SERVICE of Defendants Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd's Objections and Responses to Plaintiffs' Second Set of Requests for Documents and Things to Defendant (Nos. 63-95) filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc..(Bilson, David) (Entered: 01/08/2018)

2018-01-08

1

View

NOTICE OF SERVICE of Defendants' Initial Disclosures Under Paragraph 3(A) of the Default Standard for Discovery filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc..(Bilson, David) (Entered: 01/09/2018)

2018-01-09

1

View

NOTICE OF SERVICE of Plaintiffs' Disclosures Relating to Electronically Stored Information filed by Orexo AB, Orexo US, Inc..(Fahnestock, Derek) (Entered: 01/09/2018)

2018-01-09

1

View

NOTICE OF SERVICE of Defendants Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Ltd.'s Objections and Responses to Plaintiffs' First Set of Interrogatories filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc..(Bilson, David) (Entered: 01/11/2018)

2018-01-11

1

View

Joint STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to January 26, 2018 - filed by Orexo AB, Orexo US, Inc.. (Fahnestock, Derek) (Entered: 01/12/2018)

2018-01-12

1

View

Letter to The Honorable Gregory M. Sleet from John C. Phillips, Jr. regarding Answering Letter Brief Regarding Issues of Preclusion - re 53 Letter. (Phillips, John) (Entered: 01/12/2018)

2018-01-12

1

View

NOTICE OF SERVICE of (1) Plaintiffs' Second Set of Interrogatories to Defendants (Interrogatory Nos. 2-7); and (2) Plaintiffs' Third Set of Requests for Documents and Things to Defendants (Request Nos. 97-113) filed by Orexo AB, Orexo US, Inc..(Fahnestock, Derek) (Entered: 01/12/2018)

2018-01-12

1

View

Letter to The Honorable Gregory M. Sleet from Derek J. Fahnestock regarding reply to Defendants' January 12th letter concerning issue preclusion - re 60 Letter. (Attachments: # 1 Exhibit D-G)(Fahnestock, Derek) (Entered: 01/19/2018)

2018-01-19

1

View

Letter to The Honorable Gregory M. Sleet from Derek J. Fahnestock regarding reply to Defendants' January 12th letter concerning issue preclusion - re 60 Letter. (Attachments: # 1 Exhibit D-G)(Fahnestock, Derek) (Entered: 01/19/2018)

2018-01-19

2

View

MOTION to Dismiss for Failure to State a Claim, MOTION to Strike 50 Answer to Complaint,, Counterclaim, Affirmative Defenses - filed by Orexo AB, Orexo US, Inc.. (Fahnestock, Derek) Modified on 1/22/2018 (mdb). (Entered: 01/19/2018)

2018-01-19

1

View

OPENING BRIEF in Support re 63 MOTION to Dismiss for Failure to State a Claim, MOTION to Strike 50 Answer to Complaint,, Counterclaim, Affirmative Defenses filed by Orexo AB, Orexo US, Inc..Answering Brief/Response due date per Local Rules is 2/2/2018. (Fahnestock, Derek) Modified on 1/22/2018 (mdb). (Entered: 01/19/2018)

2018-01-19

1

View

NOTICE OF SERVICE of Plaintiffs' Initial Infringement Claim Charts filed by Orexo AB, Orexo US, Inc..(Fahnestock, Derek) (Entered: 01/22/2018)

2018-01-22

1

View

STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to February 9, 2018 - filed by Orexo AB, Orexo US, Inc.. (Fahnestock, Derek) (Entered: 01/26/2018)

2018-01-26

1

View

ORDER: On or before March 1, 2018, each party or each party group shall email to Chief Magistrate Judge Thynge, with a copy to her Judicial Administrator, Cathleen Kennedy, the information requested in this Order. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 2/1/18. (cak) (Entered: 02/01/2018)

2018-02-01

1

View

[SEALED] ANSWERING BRIEF in Opposition re 63 MOTION to Dismiss for Failure to State a Claim MOTION to Strike 50 Answer to Complaint, Counterclaim, Affirmative Defenses filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc..Reply Brief due date per Local Rules is 2/9/2018. (Attachments: # 1 Exhibit 1)(Phillips, John) (Entered: 02/02/2018)

2018-02-02

1

View

NOTICE requesting Clerk to remove Jordan D. Mobley as co-counsel. Reason for request: No longer with Winston & Strawn LLP. (Bilson, David) (Entered: 02/09/2018)

2018-02-09

1

View

REDACTED VERSION of 68 Answering Brief in Opposition, by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit 1)(Phillips, John) (Entered: 02/09/2018)

2018-02-09

1

View

REDACTED VERSION of 68 Answering Brief in Opposition, by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit 1)(Phillips, John) (Entered: 02/09/2018)

2018-02-09

2

View

STIPULATION TO EXTEND TIME for Parties to Submit a Proposed Protective Order to February 23, 2018 - filed by Orexo AB, Orexo US, Inc.. (Fahnestock, Derek) (Entered: 02/09/2018)

2018-02-09

1

View

REPLY BRIEF re 63 MOTION to Dismiss for Failure to State a Claim MOTION to Strike 50 Answer to Complaint, Counterclaim, Affirmative Defenses filed by Orexo AB, Orexo US, Inc.. (Fahnestock, Derek) (mdb). (Entered: 02/09/2018)

2018-02-09

1

View

NOTICE OF SERVICE of Defendants' (1) [CONFIDENTIAL] Objections and Responses to Plaintiffs' Second Set of Interrogatories and (2) Objections and Responses to Plaintiffs' Third Set of Requests for Documents and Things to Defendant (Nos. 96-113) filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc..(Bilson, David) (Entered: 02/12/2018)

2018-02-12

1

View

MOTION for Pro Hac Vice Appearance of Attorney Laura B. Greenspan - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Certification of Laura B. Greenspan)(Bilson, David) (Entered: 02/21/2018)

2018-02-21

1

View

MOTION for Pro Hac Vice Appearance of Attorney Laura B. Greenspan - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Certification of Laura B. Greenspan)(Bilson, David) (Entered: 02/21/2018)

2018-02-21

2

View

PROPOSED ORDER Stipulated Protective Order by Orexo AB, Orexo US, Inc.. (Fahnestock, Derek) (Entered: 02/22/2018)

2018-02-22

1

View

Joint STIPULATION TO EXTEND TIME for the parties to provide a Joint Agenda Letterfor the April 10, 2018 discovery dispute teleconference to April 6, 2018 - filed by Orexo AB, Orexo US, Inc.. (Fahnestock, Derek) (Entered: 04/05/2018)

2018-04-05

1

View

Letter to The Honorable Gregory M. Sleet from John C. Phillips, Jr. regarding Agenda for April 10, 2018 Teleconference. (Phillips, John) (Entered: 04/06/2018)

2018-04-06

1

View

Official Transcript of Teleconference held on 04 10 18 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 5/3/2018. Redacted Transcript Deadline set for 5/14/2018. Release of Transcript Restriction set for 7/11/2018. (kjm) (Entered: 04/12/2018)

2018-04-12

1

View

STIPULATION and (Proposed) Order Regarding Briefing Schedule by Orexo AB, Orexo US, Inc.. (Fahnestock, Derek) (Entered: 04/12/2018)

2018-04-12

1

View

SO ORDERED - re 79 Stipulation and (Proposed) Order Regarding Briefing Schedule. Plaintiffs' Opening Letter Brief (5 pages maximum) due by 4/18/2018, Defendants' Response Letter Brief (5 pages maximum) due by 4/25/2018, Plaintiffs' Reply Letter Brief (3 pages maximum) due by 4/30/2018. Signed by Judge Gregory M. Sleet on 4/16/2018. (mdb) (Entered: 04/16/2018)

2018-04-16

1

View

NOTICE OF SERVICE of (1) Defendants' Second Set of Interrogatories to Plaintiffs (No. 14); and (2) Defendants' Second Set of Requests to Plaintiffs for the Production of Documents (Nos. 121-127) filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc..(Bilson, David) (Entered: 04/17/2018)

2018-04-17

1

View

Letter to The Honorable Gregory M. Sleet from Derek J. Fahnestock regarding regarding Claim Construction. (Attachments: # 1 Exhibit A-G)(Fahnestock, Derek) (Entered: 04/18/2018)

2018-04-18

1

View

Letter to The Honorable Gregory M. Sleet from Derek J. Fahnestock regarding regarding Claim Construction. (Attachments: # 1 Exhibit A-G)(Fahnestock, Derek) (Entered: 04/18/2018)

2018-04-18

2

View

NOTICE OF SERVICE of Plaintiffs' Fourth Set of Requests for Documents and Things to Defendants (Request Nos. 114-128) filed by Orexo AB, Orexo US, Inc..(Fahnestock, Derek) (Entered: 04/18/2018)

2018-04-18

1

View

Letter to The Honorable Gregory M. Sleet from John C. Phillips, Jr. regarding Claim Construction. (Attachments: # 1 Exhibit 1 - 2)(Phillips, John) (Entered: 04/25/2018)

2018-04-25

1

View

Letter to The Honorable Gregory M. Sleet from John C. Phillips, Jr. regarding Claim Construction. (Attachments: # 1 Exhibit 1 - 2)(Phillips, John) (Entered: 04/25/2018)

2018-04-25

2

View

Letter to The Honorable Gregory M. Sleet from Derek J. Fahnestock regarding Reply re Claim Construction. (Fahnestock, Derek) (Entered: 04/30/2018)

2018-04-30

1

View

NOTICE OF SERVICE of (1) Plaintiffs' Responses and Objections to Defendants' Second Set of Interrogatories (No. 14); and (2) Plaintiffs' Responses and Objections to Defendants' Second Set of Requests for the Production of Documents and Things (Nos. 121-127) filed by Orexo AB, Orexo US, Inc..(Fahnestock, Derek) (Entered: 05/17/2018)

2018-05-17

1

View

NOTICE OF SERVICE of (1) Defendants Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals Industries, Ltd's Objections and Responses to Plaintiffs' Fourth Set of Requests for Documents and Things to Defendants (Nos. 114-128); (2) Defendants' [CONFIDENTIAL] Amended and Supplemental Objections and Responses to Plaintiffs' Interrogatory No. 5 filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc..(Bilson, David) (Entered: 05/18/2018)

2018-05-18

1

View

NOTICE to Take Deposition of Ramaprasad (Venkatarama) Yarasani on June 14, 2018 filed by Orexo AB, Orexo US, Inc..(Fahnestock, Derek) (Entered: 05/29/2018)

2018-05-29

1

View

NOTICE to Take Deposition of Napoleon Clark on June 12, 2018 filed by Orexo AB, Orexo US, Inc..(Fahnestock, Derek) (Entered: 05/29/2018)

2018-05-29

1

View

NOTICE OF SERVICE of Defendants' Third Set of Interrogatories to Plaintiffs (Nos. 15-18) filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc..(Bilson, David) (Entered: 06/05/2018)

2018-06-05

1

View

[SEALED] NOTICE to Take Deposition of Orexo AB and Orexo US, Inc. on June 29, 2018 filed by Actavis Elizabeth LLC, Actavis Pharma, Inc..(Phillips, John) (Entered: 06/05/2018)

2018-06-05

1

View

NOTICE OF SERVICE of Defendants' [CONFIDENTIAL] Fourth Set of Interrogatories to Plaintiffs (Nos. 19-21) filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc..(Bilson, David) (Entered: 06/06/2018)

2018-06-06

1

View

[SEALED] NOTICE to Take Deposition of Defendants on June 20, 2018 filed by Orexo AB, Orexo US, Inc..(Fahnestock, Derek) (Entered: 06/06/2018)

2018-06-06

1

View

NOTICE to Take Deposition of Rajendra Patel on June 22, 2018 filed by Orexo AB, Orexo US, Inc..(Fahnestock, Derek) (Entered: 06/06/2018)

2018-06-06

1

View

NOTICE OF SERVICE of (1) Plaintiffs' Third Set of Interrogatories to Defendants (Interrogatory Nos. 8-12); and (2) Plaintiffs' First Set of Requests for Admission to Defendant (Nos. 1-120) filed by Orexo AB, Orexo US, Inc..(Fahnestock, Derek) (Entered: 06/06/2018)

2018-06-06

1

View

~Util - Set Deadlines

2018-06-07

1

View

NOTICE to Take Deposition of 30(b)(1) Deposition of Johannes Doll on June 28, 2018 filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc..(Phillips, John) (Entered: 06/08/2018)

2018-06-08

1

View

NOTICE to Take Deposition of 30(b)(1) Deposition of Robert DeLuca on June 27, 2018 filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc..(Phillips, John) (Entered: 06/08/2018)

2018-06-08

1

View

NOTICE to Take Deposition of 30(b)(1) Deposition of Joseph DeFeo on June 26, 2018 filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc..(Phillips, John) (Entered: 06/08/2018)

2018-06-08

1

View

NOTICE to Take Deposition of 30(b)1) Deposition of Robert Ronn on June 25, 2018 filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc..(Phillips, John) (Entered: 06/08/2018)

2018-06-08

1

View

Overview

Parties

Defendant

Teva Pharmaceutical Industries, Ltd. Follow

Represented By

Teva Pharmaceuticals USA, Inc. Follow

Represented By

Actavis Pharma, Inc. Follow

Represented By

Actavis Elizabeth LLC Follow

Represented By

Plaintiff

Orexo US, Inc. Follow

Represented By

Orexo AB Follow

Represented By

Special Master

Judge Charles H. Toliver, IV Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) (Entered: 02/28/2017)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,454,996 B2. (ceg) (Entered: 02/28/2017)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Orexo AB for Orexo US, Inc. filed by Orexo AB, Orexo US, Inc. (ceg) (Entered: 02/28/2017)

SUMMONS Returned Executed by Orexo US, Inc., Orexo AB. Actavis Elizabeth LLC served on 3/1/2017, answer due 3/22/2017. (Fahnestock, Derek) (Entered: 03/01/2017)

SUMMONS Returned Executed by Orexo US, Inc., Orexo AB. Actavis Pharma, Inc. served on 3/1/2017, answer due 3/22/2017. (Fahnestock, Derek) (Entered: 03/01/2017)

SUMMONS Returned Executed by Orexo US, Inc., Orexo AB. Teva Pharmaceuticals USA, Inc. served on 3/1/2017, answer due 3/22/2017. (Fahnestock, Derek) (Entered: 03/01/2017)

STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to April 21, 2017 - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Phillips, John) (Entered: 03/16/2017)

SUMMONS Returned Executed by Orexo US, Inc., Orexo AB. Teva Pharmaceutical Industries, Ltd. served on 3/17/2017, answer due 4/21/2017. (Fahnestock, Derek) (Entered: 03/21/2017)

MOTION for Pro Hac Vice Appearance of Attorney Errol B. Taylor, Fredrick M. Zullow, Anna Brook, Jordan P. Markham, and Kyanna Lewis - filed by Orexo AB, Orexo US, Inc.. (Fahnestock, Derek) (Entered: 03/21/2017)

STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to April 28, 2017 - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Bilson, David) (Entered: 04/20/2017)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceuticals Industries Ltd. for Actavis Elizabeth LLC filed by Actavis Elizabeth LLC. (Phillips, John) (Entered: 04/28/2017)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Actavis Pharma, Inc. filed by Actavis Pharma, Inc.. (Phillips, John) (Entered: 04/28/2017)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Phillips, John) (Entered: 04/28/2017)

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Teva Pharmaceutical Industries, Ltd.. (Phillips, John) (Entered: 04/28/2017)

REDACTED VERSION of 14 Opening Brief in Support, by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibits)(Phillips, John) (Entered: 05/05/2017)

REDACTED VERSION of 14 Opening Brief in Support, by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibits)(Phillips, John) (Entered: 05/05/2017)

MOTION for Pro Hac Vice Appearance of Attorney Michael K. Nutter - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Certification of Michael K. Nutter)(Bilson, David) (Entered: 05/11/2017)

MOTION for Pro Hac Vice Appearance of Attorney Michael K. Nutter - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Certification of Michael K. Nutter)(Bilson, David) (Entered: 05/11/2017)

REDACTED VERSION of 22 Answering Brief in Opposition, by Orexo AB, Orexo US, Inc.. (Attachments: # 1 Exhibit A-I)(Fahnestock, Derek) (Entered: 05/19/2017)

REDACTED VERSION of 22 Answering Brief in Opposition, by Orexo AB, Orexo US, Inc.. (Attachments: # 1 Exhibit A-I)(Fahnestock, Derek) (Entered: 05/19/2017)

REDACTED VERSION of 24 Reply Brief, by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit H)(Phillips, John) (Entered: 05/26/2017)

REDACTED VERSION of 24 Reply Brief, by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit H)(Phillips, John) (Entered: 05/26/2017)

MOTION to Stay Discovery - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Text of Proposed Order)(Phillips, John) Modified on 7/11/2017 (mdb). (Entered: 07/11/2017)

MOTION to Stay Discovery - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Text of Proposed Order)(Phillips, John) Modified on 7/11/2017 (mdb). (Entered: 07/11/2017)

ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 7/11/2017. (asw) (Entered: 07/11/2017)

ANSWERING BRIEF in Opposition re 26 MOTION to Stay Discovery filed by Orexo AB, Orexo US, Inc..Reply Brief due date per Local Rules is 8/1/2017. (Attachments: # 1 Exhibits A-E)(Fahnestock, Derek) (Entered: 07/25/2017)

ANSWERING BRIEF in Opposition re 26 MOTION to Stay Discovery filed by Orexo AB, Orexo US, Inc..Reply Brief due date per Local Rules is 8/1/2017. (Attachments: # 1 Exhibits A-E)(Fahnestock, Derek) (Entered: 07/25/2017)

REPLY BRIEF re 26 MOTION to Stay Discovery filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Phillips, John) (Entered: 08/01/2017)

Joint STATUS REPORT by Orexo AB, Orexo US, Inc.. (Fahnestock, Derek) (Entered: 08/10/2017)

Joint PROPOSED ORDER - [Proposed] Scheduling Order by Orexo AB, Orexo US, Inc.. (Fahnestock, Derek) (Entered: 08/10/2017)

NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Documents and Things to Defendant (Request Nos. 1-62) filed by Orexo AB, Orexo US, Inc..(Fahnestock, Derek) (Entered: 08/16/2017)

ORDER appointing Special Master: Charles H. Toliver, IV appointed. See order for details. Signed by Judge Gregory M. Sleet on 10/10/2017. (mdb) (Entered: 10/10/2017)

MOTION for Pro Hac Vice Appearance of Attorney Jordan D. Mobley - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Certification of Jordan D. Mobley)(Bilson, David) (Entered: 10/16/2017)

MOTION for Pro Hac Vice Appearance of Attorney Jordan D. Mobley - filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Certification of Jordan D. Mobley)(Bilson, David) (Entered: 10/16/2017)

PROPOSED ORDER - GRANTED - Order Under Rule 502(d) Of The Federal Rules of Evidence re 38 Order Appointing Special Master by Charles H. Toliver, IV. (Toliver, Charles) (Entered: 10/17/2017)

PROPOSED ORDER -- Scheduling Order -- by Orexo AB, Orexo US, Inc.. (Attachments: # 1 Letter to the Honorable Gregory M. Sleet)(Fahnestock, Derek) (Entered: 11/03/2017)

PROPOSED ORDER -- Scheduling Order -- by Orexo AB, Orexo US, Inc.. (Attachments: # 1 Letter to the Honorable Gregory M. Sleet)(Fahnestock, Derek) (Entered: 11/03/2017)

NOTICE OF SERVICE of Initial Disclosures of Plaintiffs Orexo AB and Orexo US, Inc. Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Orexo AB, Orexo US, Inc..(Fahnestock, Derek) (Entered: 11/14/2017)

PROPOSED ORDER -- Scheduling Order -- by Orexo AB, Orexo US, Inc.. (Attachments: # 1 Letter to the Honorable Gregory M. Sleet)(Fahnestock, Derek) (Entered: 12/08/2017)

PROPOSED ORDER -- Scheduling Order -- by Orexo AB, Orexo US, Inc.. (Attachments: # 1 Letter to the Honorable Gregory M. Sleet)(Fahnestock, Derek) (Entered: 12/08/2017)

NOTICE OF SERVICE of (1) Plaintiffs' Second Set of Requests for Documents and Things to Defendant (Request Nos. 63-95); (2) Plaintiffs' Delaware Default Standard 4(a) Disclosure filed by Orexo AB, Orexo US, Inc..(Fahnestock, Derek) (Entered: 12/08/2017)

NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Defendants (Interrogatory No. 1) filed by Orexo AB, Orexo US, Inc..(Fahnestock, Derek) (Entered: 12/12/2017)

ANSWER to 1 Complaint, with Jury Demand, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Actavis Pharma, Inc., Actavis Elizabeth LLC, Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries, Ltd..(Phillips, John) Modified on 12/18/2017 (mdb). (Entered: 12/15/2017)

REDACTED VERSION of CORRECTING ENTRY:, 50 Answer to Complaint,, Counterclaim, by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Phillips, John) (Entered: 12/15/2017)

Joint STIPULATION TO EXTEND TIME for Plaintiffs to answer, move, or otherwise respond to Defendants' Answer, Affirmative Defenses, and Counterclaims [D.I. 50] to January 19, 2018 - filed by Orexo AB, Orexo US, Inc.. (Fahnestock, Derek) (Entered: 12/27/2017)

Letter to The Honorable Gregory M. Sleet from Derek J. Fahnestock regarding Plaintiffs' Opening Letter Brief Regarding Issue Preclusion. (Attachments: # 1 Exhibit A-C)(Fahnestock, Derek) (Entered: 12/29/2017)

Letter to The Honorable Gregory M. Sleet from Derek J. Fahnestock regarding Plaintiffs' Opening Letter Brief Regarding Issue Preclusion. (Attachments: # 1 Exhibit A-C)(Fahnestock, Derek) (Entered: 12/29/2017)

NOTICE OF SERVICE of Defendants' Initial Disclosures Under Paragraph 3(A) of the Default Standard for Discovery filed by Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc..(Bilson, David) (Entered: 01/09/2018)

NOTICE OF SERVICE of Plaintiffs' Disclosures Relating to Electronically Stored Information filed by Orexo AB, Orexo US, Inc..(Fahnestock, Derek) (Entered: 01/09/2018)

Joint STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to January 26, 2018 - filed by Orexo AB, Orexo US, Inc.. (Fahnestock, Derek) (Entered: 01/12/2018)

Letter to The Honorable Gregory M. Sleet from John C. Phillips, Jr. regarding Answering Letter Brief Regarding Issues of Preclusion - re 53 Letter. (Phillips, John) (Entered: 01/12/2018)

NOTICE OF SERVICE of (1) Plaintiffs' Second Set of Interrogatories to Defendants (Interrogatory Nos. 2-7); and (2) Plaintiffs' Third Set of Requests for Documents and Things to Defendants (Request Nos. 97-113) filed by Orexo AB, Orexo US, Inc..(Fahnestock, Derek) (Entered: 01/12/2018)

Letter to The Honorable Gregory M. Sleet from Derek J. Fahnestock regarding reply to Defendants' January 12th letter concerning issue preclusion - re 60 Letter. (Attachments: # 1 Exhibit D-G)(Fahnestock, Derek) (Entered: 01/19/2018)

Letter to The Honorable Gregory M. Sleet from Derek J. Fahnestock regarding reply to Defendants' January 12th letter concerning issue preclusion - re 60 Letter. (Attachments: # 1 Exhibit D-G)(Fahnestock, Derek) (Entered: 01/19/2018)

MOTION to Dismiss for Failure to State a Claim, MOTION to Strike 50 Answer to Complaint,, Counterclaim, Affirmative Defenses - filed by Orexo AB, Orexo US, Inc.. (Fahnestock, Derek) Modified on 1/22/2018 (mdb). (Entered: 01/19/2018)

NOTICE OF SERVICE of Plaintiffs' Initial Infringement Claim Charts filed by Orexo AB, Orexo US, Inc..(Fahnestock, Derek) (Entered: 01/22/2018)

STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to February 9, 2018 - filed by Orexo AB, Orexo US, Inc.. (Fahnestock, Derek) (Entered: 01/26/2018)

Teva Pharmaceutical Industries, Ltd.

Teva Pharmaceuticals USA, Inc.

Actavis Pharma, Inc.

Actavis Elizabeth LLC

Orexo US, Inc.

Orexo AB

Judge Charles H. Toliver, IV